ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1340	National Cancer Institute	Html	en	Cigar Smoking and Cancer	A fact sheet about the health risks associated with cigar smoking.	U.S. cigarettes 0.435012 safe level 0.447421 daily cigar smokers 0.575561 lung disease 0.3915 U.S. Department 0.408687 Tobacco Control Research 0.449796 cigarette wrappers 0.39436 fact sheet 0.390339 smoking cigarettes 0.411876 cigar smoke 0.9529 smaller cigar 0.493729 higher level 0.393813 tobacco wrapper 0.424842 tobacco 0.68829 little cigars 0.531809 cancer-causing chemicals 0.523406 single cigar 0.473523 tobacco equivalent 0.423502 tobacco smoke 0.637174 nicotine replacement therapy 0.395273 premium cigars 0.430441 cigar tobacco 0.599849 Yes. Cigar smoke 0.635443 Cigar smoking causes 0.545544 tobacco products 0.458198	nonporous cigar wrapper 0.527496 longer smoking time 0.409949 cigar sizes 0.492999 Step-by-Step Quit Guide 0.399635 nicotine replacement products 0.450092 cigar smokers 0.686977 cigarettes 0.521293 help quitting smoking 0.41788 NCI fact sheet 0.38899 cigar smoking 0.555875 Cigar wrappers 0.48618 cigarette smoke 0.705986 heart disease 0.392368 large cigars 0.512534 esophageal cancer risks 0.38664 cigarette tobacco 0.465692 cigars 0.636157 cigarette smokers 0.616772 cigar smoking.  Journal 0.511307 oral cavity cancers 0.409515 Services.  Reducing Tobacco 0.446373 Regular cigar smokers 0.574584 oral cavity 0.439868 safe tobacco product 0.484172	CLICK HERE
1409	National Cancer Institute	Html	en	Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may influence the risk of developing ovarian, fallopian tube, and primary peritoneal cancers and about research aimed at the prevention of them.	cancer risk factors 0.421609 oral contraceptives 0.394634 cancer treatment 0.361951 Cancer prevention 0.515594 cancer prevention trials 0.422093 invasive ovarian cancer 0.476074 primary peritoneal cancers 0.449406 nonpolyposis colorectal cancer 0.387747 cancer protective factor 0.395471 decreased risk 0.397035 prevention clinical trials 0.392562 protective factors 0.425839 gene changes 0.362438 clinical trials 0.530283 Cancer Information Service 0.386071 following PDQ summaries 0.382587 PDQ cancer information 0.483395 ovarian cancer cells 0.47684 fallopian tube 0.63787 breast/ovarian cancer syndrome 0.3882 Prevention Editorial Board 0.384816 National Cancer Institute 0.445029 primary peritoneal cancer 0.60944 increased risk 0.383316	cancer information summary 0.437953 PDQ Ovarian 0.447122 breast cancer prevention 0.37908 ovarian cancer 0.978586 cancer patients 0.359808 Cancer Care page 0.379399 slightly increased risk 0.38086 Early ovarian cancer 0.493894 cancer risk factor 0.422611 PDQ summary 0.375317 cancer risk assessment 0.407064 NCI PDQ cancer 0.412389 cancer clinical trials 0.393106 risk factors 0.470948 peritoneal cancer prevention 0.426918 fallopian tubes 0.510186 cancer information summaries 0.390404 hormone replacement therapy 0.391262 comprehensive cancer information 0.390371 ovarian cancer prevention 0.478328 risk 0.594719 ovarian tissue 0.417842 ovarian cancer syndrome 0.488439	CLICK HERE
1459	National Cancer Institute	Html	en	Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®)–Health Professional Version	Endocrine and neuroendocrine neoplasias may be inherited in syndromes such as multiple endocrine neoplasia types 1 and 2 (MEN1 and MEN2), familial pheochromocytoma and paraganglioma, and Carney-Stratakis syndrome. Learn about the genetics, clinical manifestations, and management of these hereditary cancer syndromes in this expert-reviewed summary.	men1 gene 0.496062 endocrine neoplasia syndrome 0.465022 moderate-risk pathogenic variants 0.451346 Zollinger-Ellison syndrome 0.472267 gene pathogenic variant 0.461604 familial multiple endocrine 0.465896 MEN1 pathogenic variant. 0.494678 M918T pathogenic variants 0.452285 Ann Surg 0.450141 Dutch MEN1 Study 0.479758 gene pathogenic variants 0.465665 pathogenic variant detection 0.451143 pathogenic variant testing 0.449159 Common pathogenic variants 0.452259 C634R pathogenic variant 0.448895 recent Dutch MEN1 0.461537 family members 0.473057 MEN1 section 0.451905 specific pathogenic variants 0.452497 patients 0.486964 ATA-H pathogenic variants 0.452298 Preoperative multiple endocrine 0.451658 certain endocrine tumors 0.451569 Clin Endocrinol Metab 0.506906	MEN1 multicenter study 0.456509 pathogenic variant analysis 0.462761 et al. 0.511423 pancreaticoduodenal endocrine tumors 0.47075 MEN1 diagnosis 0.459578 MEN1 testing 0.457802 MEN1 pathogenic variants 0.509643 endocrine neoplasia type 0.912503 PUBMED Abstract 0.487944 multiple endocrine neoplasia 0.985247 pathogenic variants 0.602394 term pathogenic variant 0.454804 MEN1 Study Group 0.48033 pathogenic variant yield 0.450166 primary hyperparathyroidism 0.470964 RET pathogenic variant 0.455734 pathogenic variant prevalence 0.453316 RET pathogenic variants 0.474875 pancreatic endocrine tumors 0.459209 Abstract 0.518889 C634Y pathogenic variant 0.449059 calcitonin levels 0.449053 term multiple endocrine 0.45844 germline pathogenic variants 0.463296	CLICK HERE
1618	National Cancer Institute	Html	en	Late Effects of Treatment for Childhood Cancer (PDQ®)–Patient Version	The treatment of cancer may cause health problems (late effects) for childhood cancer survivors months or years after successful treatment has ended. Get information about the long-term physical, psychological and social effects of treatment for childhood cancer in this expert-reviewed summary.	childhood cancers 0.431043 cancer treatment 0.371211 body 0.373967 childhood cancer survivors 0.770496 chemotherapy 0.372336 PDQ cancer information 0.35879 total-body irradiation 0.354372 ovarian late effects 0.364333 bile duct 0.348106 talk 0.386582 chest radiation treatment 0.353115 kidney late effects 0.373747 joint late effects 0.365129 cancer information summary 0.349224 stem cell transplant 0.480939 pancreatic late effects 0.367016 heart 0.364096 symptoms 0.373794 health problems 0.529948 tests 0.430651 primary cancer diagnosis 0.352818 radiation therapy 0.438948 following 0.347799 hormone replacement therapy 0.348511	late effects 0.94258 treatment 0.571093 blood vessel 0.385075 primary cancer 0.359907 signs 0.42599 related health problems 0.511763 procedures 0.374731 National Cancer Institute 0.350345 spinal cord 0.453656 disease 0.351393 breast cancer risk 0.350432 breast cancer 0.372761 brain tumor 0.349819 thyroid late effects 0.395111 brain 0.380353 doctor 0.354325 radiation treatment 0.379126 radiation 0.476283 acute lymphoblastic leukemia 0.349699 health habits 0.363956 neuroendocrine late effects 0.359016 high blood pressure 0.347712 nonmelanoma skin cancer 0.356812 lung late effects 0.390136	CLICK HERE
1649	National Cancer Institute	Html	en	Aromatherapy and Essential Oils (PDQ®)–Patient Version	Expert-reviewed information summary about the use of aromatherapy and essential oils to improve the quality of life of cancer patients.	PDQ Aromatherapy 0.51751 cancer treatment 0.518478 modern aromatherapy 0.502296 certain essential oils 0.545828 aromatherapy training 0.496531 PDQ cancer information 0.582174 Cancer Complementary 0.49782 hormone -like effects 0.496783 clinical trials 0.646919 cancer information summary 0.54045 aromatherapy massage 0.496545 alternative cancer therapies 0.488792 clinical trial 0.515897 CAM cancer research 0.479249 patients 0.520207 cancer patients 0.499565 Aromatherapy products 0.529674 bergamot essential oil 0.494855 literature discuss aromatherapy 0.518185 NCI PDQ cancer 0.50787 cancer information database 0.486869 aromatherapy 0.710126 international aromatherapy programs 0.515466 Therapies Editorial Board 0.490712	essential oils 0.964677 cancer information 0.591001 treatment 0.540034 Complementary Therapies Editorial 0.514222 Drug Administration 0.547203 Cancer Information Specialist 0.481775 Aromatherapy research 0.515581 tree essential oils 0.64448 Cancer Information Service 0.537651 tree essential oil 0.496279 Antibacterial essential oils 0.531896 National Cancer Institute 0.639762 alternative medicine 0.561892 standard aromatherapy certification 0.518782 term aromatherapy 0.502247 orange essential oil 0.494346 aromatherapy courses 0.496618 tea tree 0.549957 cancer clinical trials 0.48888 alternative therapies 0.505894 ginger essential oil 0.493305 cancer information summaries 0.487611 cancer 0.667969 Holistic Aromatherapy 0.506338	CLICK HERE
1658	National Cancer Institute	Html	en	Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood medulloblastoma, nonmedulloblastoma embryonal tumors, and pineal tumors.	clinical trial 0.453805 treatment 0.609377 general information 0.246182 childhood cns 0.275323 nonmedulloblastoma embryonal tumors 0.299989 cancer cells 0.278431 embryonal tumors 0.938688 brain 0.391786 chemotherapy 0.262908 CNS embryonal tumors 0.85028 clinical trial search 0.248648	cancer clinical trials 0.254529 brain tumors 0.23742 stem cell rescue 0.406691 children 0.244267 radiation therapy 0.844353 clinical trials 0.725208 cancer 0.65116 standard treatment 0.256014 information 0.249598 spinal cord 0.615415 CNS embryonal tumor 0.222757	CLICK HERE
1661	National Cancer Institute	Html	en	Antineoplastons (PDQ®)–Health Professional Version	Expert-reviewed information summary about antineoplastons as a treatment for people with cancer.	various tumor suppressor 0.673325 high-risk pediatric patients 0.613742 cell lines 0.732784 antineoplaston A10. 0.614589 steady state concentration 0.632482 mean steady state 0.62987 stable disease 0.629423 tumor suppressor genes 0.670419 antineoplaston a10 0.785651 multiple brain metastases 0.666381 clinical trials 0.642258 cancer cell line 0.621623 cancer information summary 0.628466 highest tumor response 0.628298 patients 0.960903 cancer patients 0.782838 average dose 0.662612 human colon cancer 0.66679 tumor progression 0.629611 colon cancer cells 0.664834 antineoplaston treatment 0.679278 complete tumor response 0.726436 metastatic brain tumor 0.711993 study 0.663173 neutrophil apoptosis 0.623745	Human/Clinical Studies section 0.637915 neoplastic cell lines 0.689948 human blood 0.654645 cancer cells 0.75191 animal tumor systems 0.612469 National Cancer Institute 0.656232 tumor growth 0.643714 breast cancer patients 0.772855 partial tumor response 0.663127 AS2-1 0.676129 antineoplaston therapy 0.747438 white blood cell 0.631532 antineoplaston A. 0.675544 abnormal cells 0.630356 human tumor tissue. 0.623365 human urine 0.617971 antineoplastons 0.86378 experimental cancer therapy 0.633011 chronic lymphocytic leukemia 0.610232 tumor response 0.767878 objective tumor response 0.612044 naturally occurring biochemical 0.637098 antineoplastons A10 0.665762 cancer 0.805413	CLICK HERE
1993	National Cancer Institute	Html	es	Tratamiento del craneofaringioma infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del craneofaringioma infantil	radiocirugía estereotáctica 0.762185 siguientes procedimientos 0.374594 cráneo.ampliar craneotomía 0.361774 siguientes especialistas 0.367839 radioterapia causa 0.437652 vía oral 0.344906 rayos x 0.457932 PDQ Descripción 0.478828 encéfalo benignos 0.464072 rayos gamma 0.344103 efectos tardíos 0.944822 PDQ Efectos tardíos 0.500304 National Cancer Institute 0.34653 tumores benignos 0.729016	siguientes riesgos 0.333562 Instituto Nacional 0.381114 PDQ Tratamiento 0.757616 determinados cambios 0.335985 nuevos tipos 0.356873 Physician Data Query 0.470403 sistema nervioso central 0.413873 especial llamada acelerador 0.379394 Aboutâ„¢ Brain Tumors 0.36107 simple vista 0.352074 siguientes enlaces 0.33948 pequeño recipiente 0.345075 siguientes pruebas 0.387403	CLICK HERE
2037	National Cancer Institute	Html	es	Prevención del cáncer de piel (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de piel y sobre las investigaciones dirigidas a prevenir esta enfermedad.	skin cancer 0.991265 cutaneous melanoma 0.469757 Lippincott Williams 0.41932 skin cancer prevention 0.612003 prevent skin 0.440602 protectores solares 0.469609 Williams GM 0.418343 queratosis solares 0.585992 Sin embargo 0.685934 protector solar 0.843096 American Cancer Society 0.553421 Prev Med 0.458565 cancer prevention study 0.448174 case-control study 0.424296 Study Group 0.427125 DeVita VT Jr 0.43478 risk factors 0.435855 with nonmelanoma skin 0.42056 isotretinoin-basal cell carcinomas 0.418488 randomized trial 0.462527 exposición solar 0.710997 Natl Cancer Inst 0.487884 8th ed 0.41947 protección solar 0.624745 melanoma risk factors 0.418328	pruebas insuficientes 0.419855 Nambour Skin Cancer 0.466485 cell carcinomas 0.512878 Halliday GM 0.422507 Arch Dermatol 0.425176 Wilson LD 0.417928 Cancer Facts 0.43005 Aasi SZ 0.421096 nevos melanocíticos benignos 0.418665 protector solar ayuda 0.422241 controlled trial 0.45893 protector solar versus 0.425736 Epidemiol Biomarkers Prev 0.463973 exposición solar aguda 0.467654 Cancer Prevention Trial 0.454925 Thomas VD 0.418204 Reduce Actinic Cancer 0.419285 radiación uv 0.425436 randomized controlled trial 0.440826 radiación solar 0.432514 crema base 0.420169 nonmelanoma skin cancer 0.715174 radiación ultravioleta 0.572893 Cancer Study Group 0.420229	CLICK HERE
4288	National Cancer Institute	Html	en	Delirium and Cancer Treatment	Delirium is a confused mental state. Symptoms may include changes in thinking and sleeping. In cancer patients, it may be caused by medicine, dehydration, or happen at the end of life. Delirium may be mistaken for depression or dementia.	familiar possessions 0.460098 hyperactive delirium 0.731474 questions 0.420272 family member 0.493907 health care team 0.510247 brain tumors 0.464705 poor nutrition 0.45797 judgment 0.429189 awareness 0.413241 dehydration 0.454891 health care providers 0.496178 family members 0.628462 high doses 0.463949 risk factors 0.511453 Control surroundings 0.456835 patterns 0.413223 list 0.42027 bowels 0.414692 symptoms 0.455716 hypoactive delirium 0.762002 careful observation 0.458029 Early monitoring 0.462105 decision-making 0.411721 Mixed delirium 0.689111 older age 0.46515	dementia 0.412808 conditions 0.42534 mental state 0.468032 different treatments 0.463034 infection 0.411593 supportive care approaches 0.497253 sedation 0.440043 life 0.425096 causes 0.425024 certain medicines 0.522455 PDQ® summary 0.45633 end 0.425106 decisions 0.423293 behavior 0.413211 delirium 0.955275 short period 0.469724 main types 0.467622 advanced cancer 0.462991 patient changes 0.458323 withdrawal 0.412724 professional version 0.456367 doctor 0.420247 bladder 0.411574 time 0.413034	CLICK HERE